98% up by HPLC Linagliptin 668270-12-0

Category:Active Pharmaceutical Ingredients
Product Name:98% up by HPLC Linagliptin 668270-12-0
CAS No.:668270-12-0
Standard:ChP
Price(USD):0-100
Company:Sinoway Industrial Co.Ltd.

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Xiamen, China

    Main Sales Markets: North America

  • Sample Provided: no

    Payment Terms: L/C

    Product name

    Linagliptin

    CAS No.

    668270-12-0

    Molecular Formula

    C25H28N8O2

    Molecular Weight

    472.55

    Quality Standard

    98% up by HPLC

    Appearance

    Off-white to light-yellow crystalline powder

     

    COA of Linagliptin

     

    ITEMS

    SPECIFICATION

    RESULT

    Appearance

    Off-white to light-yellow crystalline powder

    Light yellow crystalline powder

    Solubility

    Soluble in methanol and sparingly soluble in 2-propanol

    Conforms

     

     

    Identity

    (1) The infrared absorption spectrum of the sample in potassium bromide dispersion is concordant with that of a similar preparation of working standard.

     

    Conforms

    (2) The retention time of the main peak of testing solution should be confirmed with the reference solution in HPLC chromatogram.

     

    Conforms

    Melting point

    200.0 。C - 206.0。C

    203.0。C - 204.5。C

    Loss on drying

    ≤ 1.0%

    0.38%

    Residual solvents

    Methanol ≤ 3000 ppm

    Isopropanol ≤ 5000 ppm

    DMF ≤ 880 ppm

    Dichloromethane ≤ 600 ppm

    ND

    4621 ppm

    ND

    ND

    Residual on ignition

    ≤ 0.1%

    0.08%

    Related substance

    Max single impurity ≤ 0.1%

    Total impurities ≤ 1.0%

    0.07%

    0.21%

    Heavy metals

    ≤ 10 ppm

    Conforms

    Isomer

    ≤ 0.15%

    ND

    Assay

    98.0% - 102.0%

    99.89%

    Conclusion

    The sample complies with the above specification

     

    Usage

     

    Linagliptin is an inhibitor of dipeptidyl peptidase 4 (DPP-4), which degrades incretin-like polypeptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Linagliptin increases the concentration of active incretin hormones, stimulates insulin release in a glucose-dependent manner, and reduces circulating glucagon levels.

     

    Linagliptin in combination with metformin and sulfonylureas, with diet and exercise, can be used for glycemic control in adults with type II diabetes.

     

Send your message to this supplier
  • From:
  • To:
    Sinoway Industrial Co.Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service